OCI Holdings Company (A010060) Q2 2025 earnings summary

Executive summary

• Q2 2025 sales reached KRW 776 billion, with an operating loss of KRW 78 billion, reversing from profit in Q1 due to U.S. tariffs, solar policy uncertainty, and macro headwinds impacting subsidiaries.

• Operates as a holding company with 102 subsidiaries, focusing on investment, subsidiary management, and portfolio diversification.

• Main revenue sources: dividends from subsidiaries, rental income, brand usage, and service sales.

• Management is focused on strategic realignment in response to U.S. policy changes, especially the OBBB Act and Inflation Reduction Act, and maintaining financial stability.

• OCI TerraXas/TerraSus and DCRE posted significant losses, with TerraXas/TerraSus hit by declining sales and operational halts, and DCRE affected by land valuation losses.

Financial highlights

• 2025 H1 consolidated revenue: KRW 1,724.4 billion, down from KRW 3,577.4 billion in FY2024.

• Q2 2025 sales fell 18.1% quarter-over-quarter to KRW 776 billion; operating income turned to a loss of KRW 78 billion.

• Net loss attributable to owners: KRW 78.8 billion in H1 2025.

• Net debt ratio increased to 12% from 5.4% sequentially; debt-to-equity ratio at 66.5% at H1 2025.

• Cash and cash equivalents at H1 2025: KRW 781.2 billion.

Outlook and guidance

• OCI TerraXas/TerraSus plant scheduled to restart in Q3 as demand is expected to recover with new U.S. policy enactment.

• U.S. subsidiary investing in 2GW solar cell production, targeting 2026 commercial operation.

• DCRE earnings expected to normalize with construction progress; pre-sale of Complex 8 planned.

• Focus on expanding into semiconductor and battery materials, and bio-pharma investments.

• Anticipated improvement in earnings in the second half of the year as market demand recovers.